NES ZIONA, Israel--(BUSINESS WIRE)--OrSense Ltd. today received a technology innovation award from Frost & Sullivan for its NBM-200, a non-invasive monitor of blood glucose and other analyte concentrations. NBM-200 is based on “Occlusion Spectroscopy”, OrSense’s proprietary technology. This breakthrough technology enables continuous non-invasive measurement of blood glucose, hemoglobin, hematocrit, oximetry, and pulse rates with very high sensitivity.